kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS mutation: from undruggable to
KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt Tanaka 2025 Cancer Science Wiley Online Library Uncovering new therapeutic targets for a common KRAS mutation behind cancer Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



